MedTrace Logo

Dexmedetomidine and Renal Transplants

NCT02019121 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 797

Last updated 2022-07-11

No results posted yet for this study

Summary

Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine administration, these include (but are not limited to) UOP, Cr/GFR, morbidity, mortality, in hospital complications and failure rate. Investigators will research both living and cadaveric renal transplants.

Conditions

  • Renal Failure

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Hong Liu, M.D. · University of California, Davis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02019121 on ClinicalTrials.gov